EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population

Alexandre Duong iD, Ahmed El Gamal, Véronique Bilodeau, Justine Huot, Carole Delorme, Johanne Poudrette, Benoît Crevier iD, Amélie Marsot iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2024

DOI: 10.1002/phar.2941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2024. Verfasst von Alexandre Duong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Pharmacie, Université de Montréal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Drug Monitoring, Models, Biological. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds de Recherche du Québec - Santé, Réseau Québécois de Recherche sur les Médicaments.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Based on the recent guidelines for vancomycin therapeutic drug monitoring (TDM), the area under the curve to minimum inhibitory concentration ratio was to be employed combined with the usage of population pharmacokinetic (popPK) model for dosing adaptation. Yet, deploying these models in a clinical setting requires an external evaluation of their performance.

Objectives

This study aimed to evaluate existing vancomycin popPK models from the literature for the use in TDM within the general patient population in a clinical setting.

Methods

The models under external evaluation were chosen based on a review of literature covering vancomycin popPK models developed in general adult populations. Patients' data were collected from Charles‐Le Moyne Hospital (CLMH). The external evaluation was performed with NONMEM® (v7.5). Additional analyses such as evaluating the impact of number of samples on external evaluation, Bayesian forecasting, and a priori dosing regimen simulations were performed on the best performing model.

Results

Eight popPK models were evaluated with an independent dataset that included 40 patients and 252 samples. The model developed by Goti and colleagues demonstrated superior performance in diagnostic plots and population predictive performance, with bias and inaccuracy values of 0.251% and 22.7%, respectively, and for individual predictive performance, bias and inaccuracy were −4.90% and 12.1%, respectively. When limiting the independent dataset to one or two samples per patient, the Goti model exhibited inadequate predictive performance for inaccuracy, with values exceeding 30%. Moreover, the Goti model is suitable for Bayesian forecasting with at least two samples as prior for the prediction of the next trough concentration. Furthermore, the vancomycin dosing regimen that would maximize therapeutic targets of area under the curve to minimum inhibitory concentration ratio (AUC 24 /MIC) and trough concentrations ( C trough ) for the Goti model was 20 mg/kg/dose twice daily.

Conclusion

Considering the superior predictive performance and potential for Bayesian forecasting in the Goti model, future research aims to test its applicability in clinical settings at CLMH, both in a priori and a posteriori scenario.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsDrug MonitoringModels, BiologicalBayes TheoremHumansAdultMaleFemaleMiddle AgedMicrobial Sensitivity TestsArea Under CurveAged

Stichwörter der Autor:innen

Bayesian forecastingdosing regimen simulationsexternal evaluationpopPK modelingtherapeutic drug monitoringvancomycin

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Faculté de Pharmacie, Université de Montréal, Montreal, Quebec, Canada.
  • Laboratoire STP2, Faculté de Pharmacie, Université de Montréal, Montreal, Quebec, Canada.
  • Département de Pharmacie, Centre intégré de santé et de services sociaux Montérégie-Est, Longueuil, Quebec, Canada.
  • Département de Pharmacie, Centre intégré de santé et de services sociaux Montérégie-Centre, Longueuil, Quebec, Canada.
  • Centre de recherche, CHU Sainte-Justine, Montreal, Quebec, Canada.

ORCID-Profile: Alexandre Duong, Benoît Crevier, Amélie Marsot

Förderung

  • Fonds de Recherche du Québec - Santé
  • Réseau Québécois de Recherche sur les Médicaments

Zitieren

APA

Duong, A., El Gamal, A., Bilodeau, V., Huot, J., Delorme, C., Poudrette, J., Crevier, B., & Marsot, A. (2024). Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2941

Vancouver

Duong A, El Gamal A, Bilodeau V, Huot J, Delorme C, Poudrette J, et al. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2024. doi:10.1002/phar.2941

BibTeX
@article{Duong2024,
  author = {Duong, Alexandre and El Gamal, Ahmed and Bilodeau, Véronique and Huot, Justine and Delorme, Carole and Poudrette, Johanne and Crevier, Benoît and Marsot, Amélie},
  title = {Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2024},
  doi = {10.1002/phar.2941}
}
Kostenlos starten →